You just read:

PharmaEngine, Inc. and Merrimack Pharmaceuticals, Inc. Enter into a Licensing and Collaboration Agreement on PEP02 (MM-398), Nanoliposomal Irinotecan

News provided by

PharmaEngine, Inc.

May 09, 2011, 05:12 ET